NASDAQ Companies

DUBLIN, Jan. 08, 2024 (GLOBE NEWSWIRE) — Brera Holdings PLC (“Brera Holdings”, “Brera” or the “Company”) (Nasdaq: BREA) is focused […]

SOUTH SAN FRANCISCO, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq: LAB) (Standard BioTools or the Company), […]

MALMÖ, Sweden, Jan. 08, 2024 (GLOBE NEWSWIRE) — Oatly Group AB (Nasdaq: OTLY)(“Oatly” or the “Company”), the world’s original and […]

SOLANA BEACH, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling […]

MALVERN, Pa., Jan. 08, 2024 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology […]

Fourth quarter revenue expected to be $11.2 million to $11.3 million, representing growth of 56% to 58% Full year revenue […]

COPENHAGEN, Denmark, Jan. 08, 2024 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio […]

MALTA, N.Y., Jan. 08, 2024 (GLOBE NEWSWIRE) — GlobalFoundries (NASDAQ: GFS) today announced that it will host a conference call […]

Strategic prioritization of clinical programs with focus on MT-601 in patients with lymphoma MultiTAA-specific T cell therapies demonstrate clinical safety […]

Seeks dismissal of all claims related to ‘793 patent based on prior findings of invalidity which have been affirmed by […]